|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||501.00 - 509.00|
|52-week range||501.00 - 509.00|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||43.53|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
It hasn't been the best quarter for Lonza Group AG ( VTX:LONN ) shareholders, since the share price has fallen 16% in...
Lonza Group AG / Key word(s): Product LaunchLonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine 01.11.2022 / 07:00 CET/CEST Lonza meets pressing market need by launching first ever coating-free capsule to support intestinal delivery of acid-sensitive APIs Innovative Capsugel® Enprotect™ capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelinesBasel, Switzerland, 1 November 2022 – Lonza,